Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDYL | Q9Y232 | 1/20 | 0.53 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | RAD52 | P43351 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | NQO2 | P16083 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7808904 | 0.91 | CDYL (0.63) | CDYLMTNR1ATDP1KDM4ECHRM5 | |
| SCHEMBL5655818 | 0.85 | TDP1 (0.53) | CDYLMTNR1ATDP1KDM4ECHRM5 | |
| SCHEMBL20917770 | 0.85 | TDP1 (0.51) | CDYLMTNR1ATDP1KDM4ECHRM5 | |
| SCHEMBL31467476 | 0.84 | CDYL (0.49) | CDYLMTNR1ATDP1KDM4ECHRM5 | |
| SCHEMBL68440 | 0.84 | CDYL (0.49) | CDYLMTNR1ATDP1KDM4ECHRM5 | |
| SCHEMBL6421722 | 0.83 | MTNR1A (0.58) | CDYLMTNR1ATDP1KDM4ECHRM5 | |
| SCHEMBL6421718 | 0.83 | TDP1 (0.50) | CDYLMTNR1ATDP1KDM4ECHRM5 | |
| SCHEMBL487420 | 0.83 | KMT2A (0.55) | TDP1KDM4EALDH1A1SIRT5ATM | |
| Hydrochloric Acid SCHEMBL31467475 | 0.82 | CDYL (0.47) | CDYLMTNR1ATDP1KDM4ECHRM5 | |
| SCHEMBL6994900 | 0.81 | RAD52 (0.48) | RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1028962-B1 | CARBAPENEM ANTIBACTERIAL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT | MERCK & CO INC (US) | 2003-04-23 | — | — | EP | disclosed |
| EP-1023062-B1 | ANTIBACTERIAL CARBAPENEMS, COMPOSITIONS AND METHODS OF TREATMENT | MERCK & CO INC (US) | 2002-12-18 | — | — | EP | disclosed |
| US-6399597-B1 | CARBAPENICILLIN ANTIBIOTICS | MERCK & CO., INC. | 2002-06-04 | — | — | US | disclosed |
| EP-1032383-A4 | ANTIBACTERIAL CARBAPENEMS, COMPOSITIONS AND METHODS OF TREATMEMT | MERCK & CO INC (US) | 2001-11-21 | — | — | EP | disclosed |
| EP-1028962-A4 | CARBAPENEM ANTIBACTERIAL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT | MERCK & CO INC (US) | 2001-11-21 | — | — | EP | disclosed |
| EP-1023062-A4 | ANTIBACTERIAL CARBAPENEMS, COMPOSITIONS AND METHODS OF TREATMENT | MERCK & CO INC (US) | 2001-11-21 | — | — | EP | disclosed |
| US-6294529-B1 | ANTIBIOTICS BACTERICIDES | MERCK & CO., INC. | 2001-09-25 | — | — | US | disclosed |
| EP-1027352-A4 | CARBAPENEM ANTIBACTERIAL COMPOUNDS, COMPOSITIONS AND METHODS OF TREATMENT | MERCK & CO INC (US) | 2001-09-19 | — | — | EP | disclosed |
| US-6140318-A | FOR TREATING BACTERIAL INFECTIONS | MERCK & CO., INC. (US) | 2000-10-31 | — | — | US | disclosed |
| EP-1032383-A1 | ANTIBACTERIAL CARBAPENEMS, COMPOSITIONS AND METHODS OF TREATMEMT | Merck & Co., Inc. (US) | 2000-09-06 | — | — | EP | disclosed |
| EP-1027352-A1 | CARBAPENEM ANTIBACTERIAL COMPOUNDS, COMPOSITIONS AND METHODS OF TREATMENT | Merck & Co., Inc. (US) | 2000-08-16 | — | — | EP | disclosed |
| EP-1023062-A1 | ANTIBACTERIAL CARBAPENEMS, COMPOSITIONS AND METHODS OF TREATMENT | Merck & Co., Inc. (US) | 2000-08-02 | — | — | EP | disclosed |
| US-6008212-A | ANTIBIOTICS AGAINST METHICILLIN RESISTANT STAPHYLOCOCCI | MERCK & CO., INC. (US) | 1999-12-28 | — | — | US | disclosed |
| US-5994345-A | ANTIBIOTICS | MERCK & CO., INC. (US) | 1999-11-30 | — | — | US | disclosed |
| WO-1999020269-A1 | ANTIBACTERIAL CARBAPENEMS, COMPOSITIONS AND METHODS OF TREATMEMT | MERCK & CO., INC. (US) | 1999-04-29 | — | — | WO | disclosed |
| WO-1999020627-A1 | CARBAPENEM ANTIBACTERIAL COMPOUNDS, COMPOSITIONS AND METHODS OF TREATMENT | MERCK & CO., INC. (US) | 1999-04-29 | — | — | WO | disclosed |
| WO-1999020628-A1 | CARBAPENEM ANTIBACTERIAL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT | MERCK & CO., INC. (US) | 1999-04-29 | — | — | WO | disclosed |
| WO-1999018954-A1 | ANTIBACTERIAL CARBAPENEMS, COMPOSITIONS AND METHODS OF TREATMENT | MERCK & CO., INC. (US) | 1999-04-22 | — | — | WO | disclosed |
| US-5559267-A | ENANTIOMORPHS, STEREOCHEMICAL CONTROL AND ASSYMETRIC INDUCTION, HYDROGENATION OF UNSATURATED ESTERS, COORDINATION CATALYSTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-09-24 | — | — | US | disclosed |
| EP-0592552-A1 | CHIRAL PHOSPHOLANES VIA CHIRAL 1,4-DIOL CYCLIC SULFATES. | DU PONT (US) | 1994-04-20 | — | — | EP | disclosed |